Cell
Harnessing immune cell therapies for improved clinical response in solid tumors
About the Session
- Major issues to be addressed for developing immune cell therapies targeting solid tumors
- Possible strategies to address the issues
- Introduction of the immunotherapy portfolio in Biosyngen